1. Home
  2. ADMA vs GEF Comparison

ADMA vs GEF Comparison

Compare ADMA & GEF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADMA
  • GEF
  • Stock Information
  • Founded
  • ADMA 2004
  • GEF 1877
  • Country
  • ADMA United States
  • GEF United States
  • Employees
  • ADMA N/A
  • GEF N/A
  • Industry
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • GEF
  • Sector
  • ADMA Health Care
  • GEF
  • Exchange
  • ADMA Nasdaq
  • GEF Nasdaq
  • Market Cap
  • ADMA 3.7B
  • GEF 3.5B
  • IPO Year
  • ADMA N/A
  • GEF N/A
  • Fundamental
  • Price
  • ADMA $15.05
  • GEF $60.85
  • Analyst Decision
  • ADMA Strong Buy
  • GEF Hold
  • Analyst Count
  • ADMA 3
  • GEF 4
  • Target Price
  • ADMA $27.67
  • GEF $69.25
  • AVG Volume (30 Days)
  • ADMA 3.1M
  • GEF 162.4K
  • Earning Date
  • ADMA 11-06-2025
  • GEF 11-05-2025
  • Dividend Yield
  • ADMA N/A
  • GEF 3.72%
  • EPS Growth
  • ADMA 469.09
  • GEF N/A
  • EPS
  • ADMA 0.85
  • GEF 4.00
  • Revenue
  • ADMA $474,174,000.00
  • GEF $5,432,000,000.00
  • Revenue This Year
  • ADMA $21.17
  • GEF N/A
  • Revenue Next Year
  • ADMA $26.03
  • GEF N/A
  • P/E Ratio
  • ADMA $17.41
  • GEF $15.08
  • Revenue Growth
  • ADMA 43.58
  • GEF 19.22
  • 52 Week Low
  • ADMA $13.50
  • GEF $48.23
  • 52 Week High
  • ADMA $25.67
  • GEF $73.16
  • Technical
  • Relative Strength Index (RSI)
  • ADMA 47.74
  • GEF 56.34
  • Support Level
  • ADMA $14.35
  • GEF $58.31
  • Resistance Level
  • ADMA $15.60
  • GEF $59.75
  • Average True Range (ATR)
  • ADMA 0.52
  • GEF 1.24
  • MACD
  • ADMA 0.13
  • GEF 0.37
  • Stochastic Oscillator
  • ADMA 65.17
  • GEF 94.06

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About GEF Greif Inc.

Greif Inc is a producer of industrial packaging products and services with manufacturing facilities located in many countries. It offers a comprehensive line of rigid industrial packaging products, such as steel, fiber, and plastic drums, rigid intermediate bulk containers, closure systems for industrial packaging products, transit protection products, water bottles and remanufactured and reconditioned industrial containers, and services, such as container life cycle management, blending, filling, logistics, warehousing, and other packaging services. The company operates in three reportable business segments including Global Industrial Packaging, Paper Packaging and Services, and Land Management. It operates in USA, Europe, Middle East, Africa and Asia and Other Americas.

Share on Social Networks: